Syros to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 15, 2022
March 09 2022 - 7:30AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development
of medicines that control the expression of genes, today announced
that it will host a live conference call and webcast at 8:30 a.m.
ET on Tuesday, March 15, 2022 to report its fourth quarter and full
year 2021 financial results and provide a corporate update.
To access the live conference call, please dial (866) 595-4538
(domestic) or (636) 812-6496 (international) and refer to
conference ID 9682507. A webcast of the call will also be available
on the Investors & Media section of the Syros website at
www.syros.com. An archived replay of the webcast will be available
for approximately 30 days following the presentation.
About Syros Pharmaceuticals
Syros is redefining the power of small molecules to control the
expression of genes. Based on its unique ability to elucidate
regulatory regions of the genome, Syros aims to develop medicines
that provide a profound benefit for patients with diseases that
have eluded other genomics-based approaches. Syros is advancing a
robust clinical-stage pipeline, including: tamibarotene, a
first-in-class oral selective RARα agonist in RARA-positive
patients with higher-risk myelodysplastic syndrome and acute
myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide in
patients with acute promyelocytic leukemia; and SY-5609, a highly
selective and potent oral CDK7 inhibitor in patients with select
solid tumors and blood cancers. Syros also has multiple preclinical
and discovery programs in oncology and monogenic diseases. For more
information, visit www.syros.com and follow us on Twitter
(@SyrosPharma) and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220308005033/en/
Media: Courtney Solberg Syros Pharmaceuticals
917-698-9253 csolberg@syros.com
Investor: Hannah Deresiewicz Stern Investor Relations,
Inc. 212-362-1200 hannah.deresiewicz@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Sep 2023 to Sep 2024